These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 13536997)
1. The development and biochemical characterization of resistance to azaserine in a TA 3 ascites carcinoma. SARTORELLI AC; LePAGE GA Cancer Res; 1958 May; 18(4):457-63. PubMed ID: 13536997 [No Abstract] [Full Text] [Related]
2. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide. POTTER M; LAW LW J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561 [No Abstract] [Full Text] [Related]
3. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine. SARTORELLI AC; LEPAGE GA Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368 [No Abstract] [Full Text] [Related]
4. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine. HENDERSON JF; JUNGA IG Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260 [No Abstract] [Full Text] [Related]
5. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma]. YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049 [No Abstract] [Full Text] [Related]
6. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor. ANDERSON EP; JACQUEZ JA Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221 [No Abstract] [Full Text] [Related]
7. IV. Effect of O-diazoacetyl-L-serine (azaserine) on growth of various mouse and rat tumors. SUGIURA K; STOCK CC Proc Soc Exp Biol Med; 1955 Jan; 88(1):127-9. PubMed ID: 14357363 [No Abstract] [Full Text] [Related]
8. Cytochemical effects of azaserine on Ehrlich ascites tumor cells; action on deoxyribose nucleic acid (DNA) and total protein. LINDNER A AMA Arch Pathol; 1957 Jun; 63(6):532-9. PubMed ID: 13423969 [No Abstract] [Full Text] [Related]
10. Active transport of O-diazoacetyl-L-serine and 6-diazo-5-oxo-L-norleucine in Ehrlich ascites carcinoma. JACQUEZ JA Cancer Res; 1957 Oct; 17(9):890-6. PubMed ID: 13472680 [No Abstract] [Full Text] [Related]
11. Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine. JACQUEZ JA; HUTCHISON DJ Cancer Res; 1959 May; 19(4):397-401. PubMed ID: 13652124 [No Abstract] [Full Text] [Related]
13. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes. PINE EK J Natl Cancer Inst; 1958 Nov; 21(5):973-84. PubMed ID: 13599021 [No Abstract] [Full Text] [Related]
14. The effect of o-diazoacetyl-L-serine (azaserine) on the pregnancy of the dog; a preliminary report. FRIEDMAN MH J Am Vet Med Assoc; 1957 Feb; 130(4):159-62. PubMed ID: 13416078 [No Abstract] [Full Text] [Related]
18. Observations on the action of azaserine in mammalian tissues. HENDERSON JF; LEPAGE GA; MCIVER FA Cancer Res; 1957 Jul; 17(6):609-12. PubMed ID: 13446847 [No Abstract] [Full Text] [Related]
19. Inhibition of root growth by azaserine. NORMAN AG Science; 1955 Feb; 121(3137):213-4. PubMed ID: 13237973 [No Abstract] [Full Text] [Related]
20. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine. MOORE EC; LEPAGE GA Cancer Res; 1957 Sep; 17(8):804-8. PubMed ID: 13460988 [No Abstract] [Full Text] [Related] [Next] [New Search]